These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1102567)

  • 1. The effect of glucagon on airway resistance.
    Imbruce R; Goldfedder A; Maguire W; Briscoe W; Nair S
    J Clin Pharmacol; 1975 Oct; 15(10):680-4. PubMed ID: 1102567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bronchodilator action of glucagon.
    Sherman MS; Lazar EJ; Eichacker P
    J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):908-11. PubMed ID: 3372910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an external resistance on maximum flow in chronic obstructive lung disease: implications for recognition of coincident upper airway obstruction.
    Robertson DR; Swinburn CR; Stone TN; Gibson GJ
    Thorax; 1989 Jun; 44(6):461-8. PubMed ID: 2763255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses to isoproterenol in a general population sample.
    Lorber DB; Kaltenborn W; Burrows B
    Am Rev Respir Dis; 1978 Nov; 118(5):855-61. PubMed ID: 736356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of isoprenaline on the mechanical properties of lungs and airways in healthy people and patients with obstructive lung diseases.
    Bobbaers H; Stanescu DC; Demedts SM; Clément J; Pardaens J; van de Woestijne KP
    Bull Eur Physiopathol Respir; 1976; 12(4):515-31. PubMed ID: 1087891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density dependence of maximal expiratory flow in chronic obstructive pulmonary disease.
    Meadows JA; Rodarte JR; Hyatt RE
    Am Rev Respir Dis; 1980 Jan; 121(1):47-53. PubMed ID: 7352713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between external resistances, lung function changes and maximal exercise capacity.
    Melissant CF; Lammers JW; Demedts M
    Eur Respir J; 1998 Jun; 11(6):1369-75. PubMed ID: 9657581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pulmonary function tests in detecting exercise-induced bronchoconstriction.
    Buckley JM; Souhrada JF
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):883-9. PubMed ID: 1187279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Area under the maximum expiratory flow-volume curve--a sensitive parameter in the evaluation of airway patency.
    Zapletal A; Hladíková M; Chalupová J; Svobodová T; Vávrová V
    Respiration; 2008; 75(1):40-7. PubMed ID: 17299253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of methacholine-induced bronchoconstriction in patients with chronic obstructive pulmonary disease.
    Greenspon LW; Parrish B
    Am Rev Respir Dis; 1988 Feb; 137(2):281-5. PubMed ID: 3277497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
    Schindl R; Würtz J; Hoffmann H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S99-101. PubMed ID: 2427862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind parallel study of acetylcysteine-isoproterenol and saline-isoproterenol in patients with chronic obstructive lung disease.
    Cato A; Goldstein I; Millman M
    J Int Med Res; 1977; 5(3):175-83. PubMed ID: 330289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    Phillips GD; Rafferty P; Robinson C; Holgate ST
    J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
    Tantucci C; Bruni B; Dottorini ML; Peccini F; Motolese M; Lecaillon JB; Sorbini CA; Grassi V
    Am Heart J; 1990 Aug; 120(2):467-72. PubMed ID: 2200257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC; Clément J; Van de Woestijne KP
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Volumetric correction of the maximal expiratory flow 25-75% in chronic obstructive bronchopneumopathies].
    Dull WL; Alexander MR; Kasik JE
    Rev Fr Mal Respir; 1982; 10(5):337-44. PubMed ID: 7178638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respiratory resistance measured by interrupter technique in asthmatic children. Correlation with spirometry].
    Man SC; Hodor T; Nanulescu MV
    Pneumologia; 2003; 52(3-4):217-20. PubMed ID: 18210738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness.
    Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE
    Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.